BJDX
NASDAQ HealthcareBluejay Diagnostics, Inc. - Common Stock
Medical Devices
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
๐ Market Data
| Price | $4.34 |
|---|---|
| Volume | 73,984,668 |
| Market Cap | 4.49M |
| RSI (14-Day) | 93.2 Overbought |
| 200-Day MA | $4.20 |
| 50-Day MA | $1.95 |
| 52-Week High | $16.68 |
| 52-Week Low | $1.62 |
| Forward P/E | -13.56 |
| Price / Book | 1.07 |
๐ฏ Investment Strategy Scores
BJDX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (99/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (10/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find BJDX in your text
Paste any article, transcript, or post โ the tool will extract BJDX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.